Sword Bio Appoints John Pirro as Director of Scientific Solutions
Sword Bio (“Sword”), a contract research organization that supports biotech and pharmaceutical companies with their bioanalytical needs for pre-clinical and clinical trials, announces the appointment of John Pirro as Director of Scientific Solutions.
John joins Sword with a proven track record in the contract research space, providing scientific insight, guidance, and consultation. Most recently, he was the senior scientific advisor for KCAS in their bioanalytical and biomarker group. In this position, John oversaw the operations of bioanalytical analysis for immunological assays (ADA, Nab, etc.) as well as LBA analysis for ADCs, PEG-Proteins, and mAb. John has experience working in both the pre-clinical and clinical space, which has helped clients significantly. John also has experience as a lead scientist with two major Pharmaceutical companies and is a co-inventor on a number of patents.
“I’m delighted to have John join Sword Bio as our Director of Scientific Solutions as we continue to build out our world-class team,” said David Dingott, CEO. “John’s career beginning as a bench scientist, followed by 20 years of leadership experience at CROs, makes him the perfect addition. John will be a huge asset to our current and potential partner base, giving them access to his experience and expertise in bioanalytics.”
“It is a real honor to have the opportunity to work with a company like Sword and be a part of such an amazing team,” said John. “I am so excited to be part of helping our partners with scientific analytical solutions and working with the Sword team to help our clients bring biological therapeutics into the marketplace. To me, it is gratifying that I can stand behind the service and science at Sword. I know we have a great team, led by Matt Langevin, co-founder of BioAgilytix, that focuses on delivering a bioanalytical service that is unmatched in the current marketplace as well as David Osband leading our sales and Marketing team.”
Sword Bio is a bioanalytical CRO satisfying the needs of biotech and pharmaceutical companies. The sword team is built with experts in assay development, validation, and sample analysis under Non-GLP or GLP. We support our clients with PK, biomarker, and immunogenicity assays for research, pre-clinical and clinical studies.
Sword’s team of highly experienced science and QA professionals ensures high-quality science, data integrity, and regulatory compliance through all phases of clinical development. We pride ourselves on starting industry-leading Service and turn-around time, so our clients can quickly achieve their goals.
For more information, visit www.swordbio.com.